Industry News
Circadian to start phase I trials for cancer drug after receiving IND approval
Circadian (ASX:CIR) to initiate phase I trials after receiving investigational new drug status from the Food and Drug Administration for VGX-100 anti-cancer drug. [ + ]
Clinuvel’s Scenesse sees positive trial results
A phase II study of Clinuvel’s (ASX:CUV) photoprotective Scenesse shows it is effective and safe in treating the rare disorder, erythropoietic protoporphyria (EPP). [ + ]
New Commonwealth committee for government research investments
Prof Ian Chubb will chair a new Commonwealth committee to guide government research investment.
[ + ]Protein microarray uncovers malaria immunity
Researchers at the Walter and Eliza Hall institute have revealed some enticing information about how people develop immunity to malaria, opening the door to possible diagnostics and therapies. [ + ]
JW - bold in para 1 - sense? DB Award for Gamma Knife brain treatment
A major award to research a treatment for a dangerous and silent brain abnormality has been received.
[ + ]Final submissions for $100 million global challenge
GE is calling for final submissions for its $100 million global ‘healthymagination Challenge’ aimed at accelerating innovation in breast cancer, ahead of the closing date later this month.
[ + ]Joint venture saves Living Cell Technologies from closure
A 50/50 joint venture with Japanese Otsuka Pharmaceutical Factory has injected $25 million into the company which was running perilously short on cash. [ + ]
Research for a greener and healthier future
New treatments for cancer, producing better wine and greater protection of our Great Barrier Reef are some of the benefits that could flow from over 1000 new research projects being supported by the Labor Government.
[ + ]Market Watch: Mesoblast shares down 14%
Mesoblast (ASX:MSB) has seen its share price drop 14% in the last two days after being downgraded to "underperform" by Macquarie Research. [ + ]
Biotechs receive investment interest following AusBiotech 2011
Foreign investors have expressed interest in a number of Australian biotechnology companies following the AusBiotech 2011 conference last week. [ + ]
Sartorius acquires Biohit’s liquid handling business
Sartorius concludes agreement to acquire the liquid handling business of Finnish laboratory supplier Biohit.
[ + ]Ramaciotti Awards Slideshow
The Ramaciotti Foundations are collectively one of the largest private contributors to biomedical research in Australia, and having recently celebrated their 40th anniversary, have granted more than $51 million to research projects since 1970. Last week saw the latest slew of awards and grants issued, with more than $2.6 million issued to biomedical researchers around the nation. [ + ]
Genome sequence puts roundworm on the ropes
The newly-published genome sequence of roundworm is hoped to reveal new targets for diagnosis and treatment of this pervasive pernicious parasite. [ + ]
